| Application no. and date | 01308806.7 (espacenet) (Federated) (European Patent Register), 20011016 | | Patent/reg. no. and date | DK/EP 1199071, 20060524 | | Publication date | 20020424 | | Priority no. and date | US 241532 P, 20001017 | | EP pub. no. and date |
EP 1199071 20020424 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton,
Connecticut 06340, US | | Applicant ref. no. | P11713 DK | | Inventor | Day, Wesley W
Pfizer Global Research & Development, Eastern Point Road
Groton,
Connecticut 06340, US,
Lee, Andrew G
Pfizer Global Research & Development, Eastern Point Road
Groton,
Connecticut 06340, US,
Thompson, D.,
Pfizer Global Research & Development, Eastern Point Road
Groton,
Connecticut 06340, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/40 (2006.01) , A61P 13/12 (2006.01) , A61P 9/00 (2006.01) , A61P 9/10 (2006.01) | | Title | Anvendelse af en østrogenagonist/-antagonist til at forbedre vaskulær sundhed | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
